Smartleaf Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,151
Closed -$8.06K 3643
2025
Q4
$8.06K Buy
1,151
+1,089
+1,756% +$8.53K ﹤0.01% 2476
2025
Q3
$508 Buy
+62
New +$484 ﹤0.01% 2851
2025
Q2
Sell
-807
Closed -$6.53K 2960
2025
Q1
$6.53K Hold
807
﹤0.01% 2091
2024
Q4
$7.51K Buy
807
+190
+31% +$1.83K ﹤0.01% 2102
2024
Q3
$5.22K Buy
617
+247
+67% +$2.04K ﹤0.01% 2101
2024
Q2
$3.75K Buy
+370
New +$4.51K ﹤0.01% 1945

Other funds holding TDOC

Smartleaf Asset Management's TDOC Position: Q1 2026 in Review

Smartleaf Asset Management sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 1,151 shares — an estimated $8.06K sold.

Smartleaf Asset Management first reported a position in TDOC in Q2 2024 and held it in 6 quarters. The position peaked at $8.06K in Q4 2025. 325 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Smartleaf Asset Management reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
  • Smartleaf Asset Management sold 1,151 Teladoc Health shares in Q1 2026, an estimated $8.06K.
  • Smartleaf Asset Management first reported a position in Teladoc Health in Q2 2024 and held it in 6 quarters.
  • Smartleaf Asset Management's Teladoc Health position peaked at $8.06K in Q4 2025.
  • 325 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.